PMID: 11317949Apr 25, 2001Paper

Cognitively oriented psychotherapy for early psychosis (COPE): a 1-year follow-up

The British Journal of Clinical Psychology
H JacksonP Power

Abstract

Cognitively oriented psychotherapy for early psychosis (COPE) is aimed at facilitating the adjustment of the person, and at preventing or alleviating secondary morbidity in the wake of the first psychotic episode. A total of 80 people participated in the initial trial and completed assessments on a range of outcome measures. Post-treatment assessment results from a non-randomized controlled trial of COPE have been previously reported. The present paper describes the results obtained from 51 patients who attended a follow-up assessment 1 year subsequent to the end-of-treatment assessment. The 51 patients formed three groups: (1) those who were offered and accepted COPE; (2) those who were offered COPE but refused it, and continued to receive other services from the Early Psychosis Prevention and Intervention Centre (EPPIC) (refusal subjects); and (3) those who were offered neither COPE nor any other continuing treatment from EPPIC (control subjects). At 1-year follow-up, there was only one significant difference and this was between the COPE and refusal groups on the Integration/Sealing Over (I/SO) measure (p = .008). End-of-treatment differences were mostly sustained over the 1-year follow-up period. When the complete sample of...Continue Reading

Citations

Jun 25, 2009·International Journal of Group Psychotherapy·John R SaksaScott W Woods
Apr 4, 2012·International Journal of Group Psychotherapy·Tania LecomteTil Wykes
May 4, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Rafael GafoorPhilip McGuire
May 2, 2003·The Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry·John GleesonPatrick McGorry
Jan 13, 2006·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·John Gleeson, UNKNOWN EPISODE II Research Team
Oct 27, 2015·Social Psychiatry and Psychiatric Epidemiology·S M CottonP D McGorry
Nov 1, 2007·Early Intervention in Psychiatry·Jean Addington
Mar 16, 2013·Acta Psychiatrica Scandinavica·B P F RuttenM Wichers
Sep 12, 2012·Bipolar Disorders·Stephanie McMurrichRoy H Perlis
Feb 7, 2013·Psychology and Psychotherapy·Marie-Chantal BeauchampMarc Corbière
May 14, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·A MurruE Vieta
Dec 8, 2009·Psychiatry Research·Izabela E FedyszynSusan J Paxton
May 27, 2003·Schizophrenia Research·Katherine N ThompsonSusan M Harrigan
May 24, 2006·Archives of Suicide Research : Official Journal of the International Academy for Suicide Research·Elmar Etzersdorfer, Gerhard Schell
Dec 21, 2018·The Cochrane Database of Systematic Reviews·Christopher JonesChunhu Shi
Feb 25, 2005·The Journal of Nervous and Mental Disease·John F GleesonPatrick D McGorry
Nov 2, 2006·Psychiatric Rehabilitation Journal·Elizabeth McCayTanya Vishnevsky
Jun 17, 2011·The Cochrane Database of Systematic Reviews·John BolaHaluk Soydan
Jan 14, 2012·Early Intervention in Psychiatry·Felicity FanningEadbhard O'Callaghan
Mar 25, 2017·Work : a Journal of Prevention, Assessment, and Rehabilitation·Kelly A AllottDawn I Velligan
Aug 2, 2005·The British Journal of Psychiatry. Supplement·Jean Addington, John Gleeson
Jun 17, 2011·The Cochrane Database of Systematic Reviews·Max Marshall, John Rathbone
Jul 22, 2004·Current Opinion in Psychiatry·Markus Heinimaa, Tor K Larsen
Oct 12, 2020·Australian Journal of Primary Health·Renee O DonnellHelen Skouteris

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.